PRRC2A and cancer: PRRC2A is a newly identified m6A reader protein and it acts as a critical regulator of oligodendroglial specification and myelination.[9] Interestingly, PRRC2A is upregulated in most cancers and is associated with poor survival.[10] However, the functions of PRRC2A in CRC remain unknown.